San Diego-based mostly Viking Therapeutics marked alone as a significant competitor inside the weight loss drug sector in February soon after revealing promising details from the mid-stage trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when offered being a weekly injection As well as in March th